SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:gup.ub.gu.se/43636"
 

Search: id:"swepub:oai:gup.ub.gu.se/43636" > Detection rates of ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003390naa a2200481 4500
001oai:gup.ub.gu.se/43636
003SwePub
008240528s2006 | |||||||||||000 ||eng|
0247 a https://gup.ub.gu.se/publication/436362 URI
0247 a https://doi.org/10.1002/ijc.216672 DOI
040 a (SwePub)gu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a van der Kwast, TH4 aut
2451 0a Detection rates of high-grade prostate cancer during subsequent screening visits. Results of the European Randomized Screening Study for Prostate Cancer.
264 c 2006
264 1b Wiley,c 2006
520 a Screening for prostate cancer using prostate-specific antigen (PSA) tests has led to a stage and grade shift as compared to the pre-PSA era. Effectiveness of screening for prostate cancer should be manifested by a reduction in detection rate of aggressive cancers during subsequent screening. In 6 centers of the European Randomized Screening study for Prostate Cancer, a total of 58,710 men were tested for prostate cancer. Screening centers differed with regard to age-range, screening interval and biopsy indications. During the 2nd visit, the proportion of Gleason score 6 cancers increased from 62.5 to 75%, mainly at the expense of Gleason score 7 cancers. High-grade (Gleason score 8-10) cancer detection rates varied per screening center during the 1st visit from 5.1 to 41.1, and during the 2nd visit from 6.4 to 29.3/10,000 men. The overall detection rate of high-grade cancers showed a reduction during the 2nd visit from 26 to 12/10,000 men, an effect mainly attributable to the screening center with the highest cancer detection rate (i.e. 507/10,000 men). Variations in detection rates among screening centers related among others to biopsy compliance and age range.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Urologi och njurmedicin0 (SwePub)302142 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Urology and Nephrology0 (SwePub)302142 hsv//eng
653 a prostate • screening • early detection • grade shift • cancer detection rate • ERSPC
7001 a Ciatto, S4 aut
7001 a Martikainen, PH4 aut
7001 a Hoedemaeker, R4 aut
7001 a Laurila, M4 aut
7001 a Pihl, Carl Gustafu Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences4 aut
7001 a Hugosson, Jonas,d 1955u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences4 aut0 (Swepub:gu)xhugjo
7001 a Neetens, I4 aut
7001 a Nelen, V4 aut
7001 a Di Lollo, S4 aut
7001 a Roobol, MJ4 aut
7001 a Maatanen, L4 aut
7001 a Santonja, S4 aut
7001 a Moss, S4 aut
7001 a Schröder, FH4 aut
7102 a Göteborgs universitetb Institutionen för kliniska vetenskaper4 org
7730 t Int J Cancerd : Wileyg 118:10, s. 2538-2542q 118:10<2538-2542
7730 t International Journal of Cancerd : Wileyg 118:10, s. 2538-2542q 118:10<2538-2542x 0020-7136x 1097-0215
8564 u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.21667
8564 8u https://gup.ub.gu.se/publication/43636
8564 8u https://doi.org/10.1002/ijc.21667

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view